|
|
|
501-1,000 employees
View all Spark Therapeutics, Inc. employees
|
|
Biotechnology
|
|
3737 Market Street, Suite 1300, Philadelphia, PA 19104, US
|
|
At Spark® Therapeutics, we believe in a world where no life is limited by disease.
We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our mission is to unlock the power of gene therapy to accelerate healthcare transformation.
Since our founding, we have been committed to bringing a wide range of expertise to build a fully integrated gene therapy company focused on inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver, such as hemophilia. We are seeking talented individuals with diverse experiences, abilities and interests who have the curiosity, courage and drive to reimagine a new health care paradigm.
Join us on a journey through uncharted territory – seeking to bring gene therapy to people worldwide. The resilience of the people we serve is our inspiration to break barriers, as we strive to turn genes into medicine. Spark is a member of the Roche Group.
Know that working at Spark® Therapeutics is not just another job; it is a once-in-a-lifetime opportunity. We embrace the challenges before us and the uncertainty inherent in them. Ultimately, we are working to create a world where no life is limited by disease. To learn more about Spark and our open positions, visit www.sparktx.com. You can also find us on Twitter at @Spark_tx.
|
Ron Philip is the CEO of Spark Therapeutics, Inc.. To contact Ron Philip email at [email protected] or [email protected].
The decision makers in Spark Therapeutics, Inc. are Adam Simpson, Bartholomew J Tortella, Jeremy Allen, etc. Click to Find Spark Therapeutics, Inc. decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.